Dutch healthtech company, announced that it has been awarded a €4 million Pathfinder grant from the European Innovation Council (EIC).

COPD is a prevalent global lung disease affecting nearly 400 million people and ranking as the 3rd leading cause of death worldwide. Worldwide, six percent of all deaths are caused by COPD.

The company’s mission is to enhance the well-being of COPD patients by building a sensor device for real-time, at-home patient monitoring.

respiQ